1. Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure 
Mouhab Ayas, Mary Eapen, Jennifer Le-Rademacher, Jeanette Carreras, Hisham Abdel-Azim, Blanche P. Alter, Paolo Anderlini, Minoo Battiwalla, Marc Bierings, David K. Buchbinder, Carmem Bonfim, Bruce M. Camitta, Anders L. Fasth, Robert Peter Gale, Michelle A. Lee, Troy C. Lund, Kasiani C. Myers, Richard F. Olsson, Kristin M. Page, Tim D. Prestidge, Mohamed Radhi, Ami J. Shah, Kirk R. Schultz, Baldeep Wirk, John E. Wagner, H. Joachim Deeg 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 10, Pages (October 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
The day 28 cumulative incidence of neutrophil recovery was 24% (95% CI, 13% to 37%) for patients undergoing HCT within 3 months of their first HCT (A) and 58% (95% CI, 38% to 73%) for those undergoing HCT beyond 3 months after their first HCT (B).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
The 5-year probability of overall survival was 16% (95% CI, 8% to 28%) for patients undergoing HCT within 3 months of their first HCT (A) and 45% (95% CI, 27% to 61%) for those undergoing HCT beyond 3 months after their first HCT (B).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions